Summary Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss. Market Segment as follows: By Region Asia-Pacific North America Europe South America Middle East & Africa By Type Aprotinin (From bovine lung) Recombinant Aprotinin By Application Pharmaceuticals Scientific Research & Experiment By Company Sigma-Aldrich BeiJing Geyuantianrun Bio-tech Cayman Chemical Taj Pharmaceuticals Limited Guangdong Techpool Bio-pharma Dadeli A.S.Joshi&Company Enzymeking Biotechnology AdooQ BioScience ProSpec Yaxin Biotechnology AMRESCO PanReac AppliChem Runhao The main contents of the report including: Section 1: Product definition, type and application, global and regional market overview; Section 2: Global and regional Market competition by company; Section 3: Global and regional sales revenue, volume and price by type; Section 4: Global and regional sales revenue, volume and price by application; Section 5: Regional export and import; Section 6: Company information, business overview, sales data and product specifications; Section 7: Industry chain and raw materials; Section 8: SWOT and Porter's Five Forces; Section 9: Conclusion.
Table of Contents 1 Market Overview 1.1 Market Segment Overview 1.1.1 Product Definition 1.1.2 Market by Type 1.1.2.1 Aprotinin (From bovine lung) 1.1.2.2 Recombinant Aprotinin 1.1.3 Market by Application 1.1.3.1 Pharmaceuticals 1.1.3.2 Scientific Research & Experiment 1.2 Global and Regional Market Size 1.2.1
